Andrea Olariu, MD, PhD oversees Clinical/Medical and Regulatory Affairs, Product Development, and the Quality Department at Medicines360. Since joining Medicines360 in 2010, Dr. Olariu has led the clinical and regulatory strategy resulting in successful FDA approvals of the company’s hormonal IUD, LILETTA.
Dr. Olariu has extensive experience in designing and conducting clinical trials from proof of concept to large pivotal Phase 3 studies. Prior to Medicines360, Andrea developed and implemented clinical/medical and regulatory strategies for several medical devices that received approval in the US, Canada, and the European Union.
Prior to moving to the United States, Dr. Olariu worked for over 15 years in academia, as an Associate Professor of Dermatology at the University of Szeged in Szeged, Hungary and a Senior Lecturer of Immunology at the University of Medicine and Pharmacy, Timisoara in Timisoara, Romania.
Dr. Olariu has authored over 40 peer-reviewed medical publications, is the recipient of several academic honors, and has spoken at national and international conferences.